{"title":"A Rare Case of Breast Abscess Caused by Facklamia hominis Following COVID-19 Infection.","authors":"Lei Hou, Ziyi Fan, Luming Zheng","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Facklamia hominis is an infrequent opportunistic pathogen. This case report describes a young immunocompetent female who developed recurrent abscesses after a COVID-19 infection, highlighting the potential link between post-COVID-19 immune dysfunction and opportunistic infections.</p><p><strong>Methods: </strong>A comprehensive review of the patient's clinical course, relevant laboratory tests, treatment, and post-treatment outcomes was conducted.</p><p><strong>Results: </strong>A young female patient with a history of COVID-19 infection developed recurrent abscesses (perineal and breast) 40 days apart, which were managed with antibiotics, local incision and drainage, and traditional Chinese medicine (Xihuang pills, made up with Bezoar, Musk, Frankincense, and Myrrh). Laboratory tests revealed prealbumin deficiency (143 mg/L), a marker associated with poor prognosis in post-COVID-19 patients. Bacterial culture from the breast abscess confirmed Facklamia hominis infection, identified via VITEK 2 Compact system. The patient completed a two-week regimen of antibiotics combined with traditional Chinese medicine therapy, achieving complete resolution without recurrence during follow-up.</p><p><strong>Conclusion: </strong>There is an emerging association between COVID-19 infection and subsequent Facklamia hominis infection, particularly in immunocompromised individuals. Post-COVID-19 lymphopenia and prealbumin deficiency may predispose patients to opportunistic infections.</p><p><strong>Keywords: </strong>COVID-19, Multiple abscesses, breast abscess, Facklamia homini, prealbumin.</p>","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alternative therapies in health and medicine","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Facklamia hominis is an infrequent opportunistic pathogen. This case report describes a young immunocompetent female who developed recurrent abscesses after a COVID-19 infection, highlighting the potential link between post-COVID-19 immune dysfunction and opportunistic infections.
Methods: A comprehensive review of the patient's clinical course, relevant laboratory tests, treatment, and post-treatment outcomes was conducted.
Results: A young female patient with a history of COVID-19 infection developed recurrent abscesses (perineal and breast) 40 days apart, which were managed with antibiotics, local incision and drainage, and traditional Chinese medicine (Xihuang pills, made up with Bezoar, Musk, Frankincense, and Myrrh). Laboratory tests revealed prealbumin deficiency (143 mg/L), a marker associated with poor prognosis in post-COVID-19 patients. Bacterial culture from the breast abscess confirmed Facklamia hominis infection, identified via VITEK 2 Compact system. The patient completed a two-week regimen of antibiotics combined with traditional Chinese medicine therapy, achieving complete resolution without recurrence during follow-up.
Conclusion: There is an emerging association between COVID-19 infection and subsequent Facklamia hominis infection, particularly in immunocompromised individuals. Post-COVID-19 lymphopenia and prealbumin deficiency may predispose patients to opportunistic infections.
Keywords: COVID-19, Multiple abscesses, breast abscess, Facklamia homini, prealbumin.
期刊介绍：
Launched in 1995, Alternative Therapies in Health and Medicine has a mission to promote the art and science of integrative medicine and a responsibility to improve public health. We strive to maintain the highest standards of ethical medical journalism independent of special interests that is timely, accurate, and a pleasure to read. We publish original, peer-reviewed scientific articles that provide health care providers with continuing education to promote health, prevent illness, and treat disease. Alternative Therapies in Health and Medicine was the first journal in this field to be indexed in the National Library of Medicine. In 2006, 2007, and 2008, ATHM had the highest impact factor ranking of any independently published peer-reviewed CAM journal in the United States—meaning that its research articles were cited more frequently than any other journal’s in the field.
Alternative Therapies in Health and Medicine does not endorse any particular system or method but promotes the evaluation and appropriate use of all effective therapeutic approaches. Each issue contains a variety of disciplined inquiry methods, from case reports to original scientific research to systematic reviews. The editors encourage the integration of evidence-based emerging therapies with conventional medical practices by licensed health care providers in a way that promotes a comprehensive approach to health care that is focused on wellness, prevention, and healing. Alternative Therapies in Health and Medicine hopes to inform all licensed health care practitioners about developments in fields other than their own and to foster an ongoing debate about the scientific, clinical, historical, legal, political, and cultural issues that affect all of health care.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
